Maternal RSV vaccination in the absence of a nationally funded programme: inequalities in coverage in Norway, 2024 to 2026
Year: 2026
Type: article
Study design: Observational Study
Abstract: Respiratory syncytial virus (RSV) is a leading cause of hospitalisation for lower respiratory tract infection in children. Despite not being included in Norway's national immunisation programme and requiring out-of-pocket payment, maternal RSV vaccination coverage reached 51% by September 2026. Coverage varied markedly by maternal country of birth, with lower uptake among women born outside Norway. Within Oslo, uptake appeared to reflect district-level socioeconomic factors. These inequalities suggest that lack of government funding is an important driver of unequal protection.
Source: Eurosurveillance
Institution: Norwegian Institute of Public Health
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7225399932
